# Twist Bioscience Corporation (TWST) FY2026 YTD Q3 P&L / Income Statement

- Company: Twist Bioscience Corporation (TWST)
- Period: 2025-10-01 to 2026-06-30
- Filing: Q3 FY2026 10-Q, filed 2026-08-03, accession number 0001581280-26-000047
- Page: https://plicit.ai/financials/twst/fy2026-ytd-q3-income-statement
- Chart image: https://plicit.ai/charts/twst-fy2026-ytd-q3-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2025-10-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenues**: 332,789,000 US dollars
- **Cost of revenues**: 159,241,000 US dollars
- **Gross profit (calculated)**: 173,548,000 US dollars
- **Operating expenses (calculated)**: 288,591,000 US dollars
- **Loss from operations**: negative 115,043,000 US dollars
- **Other income (expense), net (calculated)**: 6,071,000 US dollars
- **Income (loss) before income taxes**: negative 108,972,000 US dollars
- **Income tax expense**: 607,000 US dollars
- **Net (loss) income**: negative 109,579,000 US dollars
- **DNA synthesis and protein solutions**: 160,905,000 US dollars
- **NGS applications**: 171,884,000 US dollars
- **Research and development expenses**: 54,850,000 US dollars
- **Selling, general and administrative expenses**: 226,536,000 US dollars
- **Litigation settlement costs, net of recoveries**: 7,205,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/twst/fy2026-ytd-q3-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/twst-fy2026-ytd-q3-revenue-by-geography-sankey.png

Income statement for 2025-10-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenues**: 332,789,000 US dollars
- **Cost of revenues**: 159,241,000 US dollars
- **Gross profit (calculated)**: 173,548,000 US dollars
- **Operating expenses (calculated)**: 288,591,000 US dollars
- **Loss from operations**: negative 115,043,000 US dollars
- **Other income (expense), net (calculated)**: 6,071,000 US dollars
- **Income (loss) before income taxes**: negative 108,972,000 US dollars
- **Income tax expense**: 607,000 US dollars
- **Net (loss) income**: negative 109,579,000 US dollars
- **Americas**: 199,947,000 US dollars
- **EMEA**: 109,334,000 US dollars
- **Asia Pacific**: 23,508,000 US dollars
- **Research and development expenses**: 54,850,000 US dollars
- **Selling, general and administrative expenses**: 226,536,000 US dollars
- **Litigation settlement costs, net of recoveries**: 7,205,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Industry Sectors

- Page: https://plicit.ai/financials/twst/fy2026-ytd-q3-income-statement/revenue-by-industry-sectors
- Chart image: https://plicit.ai/charts/twst-fy2026-ytd-q3-revenue-by-industry-sectors-sankey.png

Income statement for 2025-10-01 through 2026-06-30. View: Industry Sectors. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenues**: 332,789,000 US dollars
- **Cost of revenues**: 159,241,000 US dollars
- **Gross profit (calculated)**: 173,548,000 US dollars
- **Operating expenses (calculated)**: 288,591,000 US dollars
- **Loss from operations**: negative 115,043,000 US dollars
- **Other income (expense), net (calculated)**: 6,071,000 US dollars
- **Income (loss) before income taxes**: negative 108,972,000 US dollars
- **Income tax expense**: 607,000 US dollars
- **Net (loss) income**: negative 109,579,000 US dollars
- **Therapeutics**: 118,404,000 US dollars
- **Diagnostics**: 119,118,000 US dollars
- **Industry and applied**: 17,667,000 US dollars
- **Academic research and government**: 40,545,000 US dollars
- **Global supply partners**: 37,055,000 US dollars
- **Research and development expenses**: 54,850,000 US dollars
- **Selling, general and administrative expenses**: 226,536,000 US dollars
- **Litigation settlement costs, net of recoveries**: 7,205,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.